CME Group Earnings Calls
| Release date | Apr 22, 2026 |
| EPS estimate | $3.34 |
| EPS actual | $3.36 |
| EPS Surprise | 0.599% |
| Revenue estimate | 1.875B |
| Revenue actual | 1.88B |
| Revenue Surprise | 0.281% |
| Release date | Feb 04, 2026 |
| EPS estimate | $2.75 |
| EPS actual | $2.77 |
| EPS Surprise | 0.727% |
| Revenue estimate | 1.647B |
| Revenue actual | 1.649B |
| Revenue Surprise | 0.0865% |
| Release date | Oct 22, 2025 |
| EPS estimate | $2.63 |
| EPS actual | $2.68 |
| EPS Surprise | 1.90% |
| Revenue estimate | 1.53B |
| Revenue actual | 1.538B |
| Revenue Surprise | 0.491% |
| Release date | Jul 23, 2025 |
| EPS estimate | $2.91 |
| EPS actual | $2.96 |
| EPS Surprise | 1.72% |
| Revenue estimate | 1.686B |
| Revenue actual | 1.692B |
| Revenue Surprise | 0.385% |
Last 4 Quarters for CME Group
Below you can see how CME performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 23, 2025 |
| Price on release | $276.48 |
| EPS estimate | $2.91 |
| EPS actual | $2.96 |
| EPS surprise | 1.72% |
| Date | Price |
|---|---|
| Jul 17, 2025 | $277.82 |
| Jul 18, 2025 | $274.70 |
| Jul 21, 2025 | $275.00 |
| Jul 22, 2025 | $274.64 |
| Jul 23, 2025 | $276.48 |
| Jul 24, 2025 | $277.18 |
| Jul 25, 2025 | $279.55 |
| Jul 28, 2025 | $274.12 |
| Jul 29, 2025 | $274.60 |
| 4 days before | -0.482% |
| 4 days after | -0.680% |
| On release day | 0.253% |
| Change in period | -1.16% |
| Release date | Oct 22, 2025 |
| Price on release | $267.81 |
| EPS estimate | $2.63 |
| EPS actual | $2.68 |
| EPS surprise | 1.90% |
| Date | Price |
|---|---|
| Oct 16, 2025 | $262.51 |
| Oct 17, 2025 | $267.94 |
| Oct 20, 2025 | $267.62 |
| Oct 21, 2025 | $268.61 |
| Oct 22, 2025 | $267.81 |
| Oct 23, 2025 | $268.90 |
| Oct 24, 2025 | $269.54 |
| Oct 27, 2025 | $271.09 |
| Oct 28, 2025 | $266.33 |
| 4 days before | 2.02% |
| 4 days after | -0.553% |
| On release day | 0.407% |
| Change in period | 1.46% |
| Release date | Feb 04, 2026 |
| Price on release | $294.62 |
| EPS estimate | $2.75 |
| EPS actual | $2.77 |
| EPS surprise | 0.727% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $289.83 |
| Jan 30, 2026 | $289.06 |
| Feb 02, 2026 | $290.77 |
| Feb 03, 2026 | $293.07 |
| Feb 04, 2026 | $294.62 |
| Feb 05, 2026 | $297.38 |
| Feb 06, 2026 | $302.27 |
| Feb 09, 2026 | $307.24 |
| Feb 10, 2026 | $306.76 |
| 4 days before | 1.65% |
| 4 days after | 4.12% |
| On release day | 0.94% |
| Change in period | 5.84% |
| Release date | Apr 22, 2026 |
| Price on release | $285.71 |
| EPS estimate | $3.34 |
| EPS actual | $3.36 |
| EPS surprise | 0.599% |
| Date | Price |
|---|---|
| Apr 16, 2026 | $296.22 |
| Apr 17, 2026 | $287.65 |
| Apr 20, 2026 | $287.45 |
| Apr 21, 2026 | $284.40 |
| Apr 22, 2026 | $285.71 |
| Apr 23, 2026 | $285.47 |
| Apr 24, 2026 | $285.03 |
| Apr 27, 2026 | $281.94 |
| Apr 28, 2026 | $284.53 |
| 4 days before | -3.55% |
| 4 days after | -0.413% |
| On release day | -0.0840% |
| Change in period | -3.95% |
CME Group Earnings Call Transcript Summary of Q1 2026
Key points for investors:
- Record volumes and broad-based growth: CME reported a record Q1 2026 average daily volume (ADV) of 36.2 million contracts, up 22% YoY and the highest quarterly ADV in company history. For the first time CME recorded simultaneous volume records across all six asset classes (rates, equities, energy, ags, metals, FX). Commodity volume rose 38% YoY; financial products volume rose 18%.
- Strong international and client traction: International ADV hit a record 11.4 million contracts (roughly +30% year-over-year) with all regions (EMEA, APAC, LATAM) at record levels. Open interest ended the quarter +11% YoY and +19% since start of 2026; U.S. Treasury open interest reached an all-time high (36.3 million contracts).
- Financial results: Record revenue of $1.9 billion (+14% YoY). Clearing & transaction fees grew 15% YoY; market data revenue was a record $224 million (+15% YoY, marking 32 consecutive quarters of YoY growth). Adjusted operating margin was 72.8% (record); adjusted net income $1.2 billion and adjusted EPS $3.36 (+20% YoY).
- Capital allocation: Returned $3.2 billion to shareholders in Q1 (≈$2.7 billion dividends + $536 million share repurchases). Management described repurchases as opportunistic and noted OSTTRA sale proceeds are being used for buybacks.
- Product, technology and strategic initiatives:
- Regulatory approval for expanded FICC (DTCC) cross-margining to end-user clients (launching 4/30) — expected meaningful collateral/margin efficiencies.
- 24/7 crypto trading planned to go live May 29.
- Filing to convert Micro Equity Index options to financial (cash) settlement to better serve micro-size users.
- Continued cloud migration with a client testing facility in Dallas (on track to open this summer) and planned agricultural product migrations to the cloud by year-end; Google is a strategic cloud partner and its preferred shares converted to common this quarter.
- Tokenization efforts (tokenized cash pilot with Google and banks) targeted to advance testing this year and go-live by year-end; exploring a CME stablecoin subject to regulatory engagement.
- BrokerTec Chicago showing early adoption in U.S. cash treasuries; prediction/event markets ramping (150,000 new accounts, >$220M contract volume since December) with material share of volumes in market-based contracts after FanDuel marketing.
- Business dynamics and headwinds: Rate-per-contract (RPC) was affected by volume tiering, mix shifts (crude vs. nat gas), and strong micro contract growth (micro energy up sharply), which reduces weighted-average RPC despite profitable incremental volume. Management emphasized the benefit of lower pricing tiers to drive incremental, high-margin volume. They also flagged regulatory/legal constraints (e.g., perpetual futures are not permitted under current U.S. law) and continued engagement with regulators on tokenization/stablecoin initiatives.
- Management view: Confident in continued client-driven growth, capital efficiency gains for customers (management cited ~$85B/day of margin savings currently) and disciplined capital allocation while remaining open to sensible M&A if it benefits shareholders.
Sign In
Buy CME